{
    "complex": false,
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "ucits": true,
    "type": "ETF",
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The Xtrackers MSCI Innovation UCITS ETF (1C) is classified as non-complex under MiFID II based on the following analysis: 1. Physical Replication: The factsheet explicitly states 'Direct Replication (physically)', confirming the ETF uses physical replication rather than synthetic methods. 2. No Leverage or Inverse Exposure: There is no mention of leverage, inverse strategies, or amplified returns in either the KIID or factsheet. 3. Minimal Derivative Usage: While the KIID mentions derivatives may be used for risk management, the factsheet clarifies this is for efficient portfolio management (e.g., hedging) rather than as a core strategy. 4. UCITS Compliance: The fund is UCITS-compliant, which inherently limits complexity. 5. Transparent Index: The underlying MSCI ACWI IMI Innovation Select Screened 200 Index is a straightforward equity index with clear selection criteria. 6. Risk Profile: The fund's risk profile (category 6) is consistent with global equity exposure and does not indicate unusual complexity. 7. No Counterparty Risk: Physical replication eliminates counterparty risk from swaps. The only potential complexity factor is the ESG screening process, but this is standard for many ETFs and does not trigger MiFID II complexity classification.",
    "confidence": 95
}